Does the pituitary somatotrope play a primary role in regulating GH output in metabolic extremes?

Annals of the New York Academy of Sciences

Volumn 1220, Issue 1, 2011, Pages 82-92

  Luque, Raul M ^a   Gahete, Manuel D ^a,b,c   Cordoba Chacon, Jose ^a   Childs, Gwen V ^d   Kineman, Rhonda D ^b,c  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Fasting; Growth hormone; Obesity; Somatotrope

Indexed keywords

GHRELIN; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; GROWTH HORMONE RELEASING FACTOR; INSULIN; INSULIN RECEPTOR; SOMATOMEDIN C RECEPTOR; SOMATOSTATIN;

ARTICLE; GENE INACTIVATION; GROWTH HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE RESISTANCE; HUMAN; HYPOPHYSIS; LOXP SITE; METABOLISM; NONHUMAN; NUTRITIONAL DEFICIENCY; OBESITY; PROTEIN FUNCTION;

EID: 79952465859     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05913.x     Document Type: Article

References (107)

1. Luque, R.M., Q. Lin & R.D. Kineman 2009. Understanding the interrelationship between metabolism and the GH-Axis. In Hypothalamic-Pituitary Disease and Obesity, 11th International HypoCCS Meeting. D.R. Clemmons & A.F. Attanasio, Eds.: 33-56. BioScientifica Ltd. Bristol, UK
2. Gahete, M.D., M. Duran-Prado, R.M. Luque, et al 2009. Understanding the multifactorial control of growth hormone release by somatotropes. Ann. N.Y. Acad. Sci. 1163: 137-153.
3. Norrelund, H. 2005. The metabolic role of growth hormone in humans with particular reference to fasting. Growth Horm. IGF Res. 15: 95-122.
4. Scacchi, M., A.I. Pincelli & F. Cavagnini 2003. Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa. Front. Neuroendocrinol. 24: 200-224.
5. Mercado, M. & G. Baumann 1995. Characteristics of the somatotropic axis in insulin dependent diabetes mellitus. Arch. Med. Res. 26: 101-109.
6. Luque, R.M., S. Park & R.D. Kineman 2007. Severity of the catabolic condition differentially modulates hypothalamic expression of growth hormone-releasing hormone (GHRH) in the fasted mouse: potential role of neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH). Endocrinology 148: 300-309.
7. Tannenbaum, G.S., J.B. Martin & E. Colle 1976. Ultradian growth hormone rhythm in the rat: effects of feeding, hyperglycemia, and insulin-induced hypoglycemia. Endocrinology 99: 720-727.
8. Giustina, A. & B. Wehrenberg 1994. Growth hormone neuroregulation in diabetes mellitus. TEM 5: 73-78.
9. Kim, E., S. Sohn, M. Lee, et al 2006. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes. J. Endocrinol. 188: 263-270.
10. Frystyk, J. 2004. Free insulin-like growth factors-measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm. IGF Res. 14: 337-375.
11. Touvier, T., F. Conte-Auriol, O. Briand, et al 2009. LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice. J. Clin. Invest. 119: 3830-3838.
12. Beauloye, V., B. Willems, V. De Coninck, et al 2002. Impairment of liver GH receptor signaling by fasting. Endocrinology 143: 792-800.
13. Gevers, E.F., M.J. Hannah, M.J. Waters & I.C.A.F. Robinson 2009. Regulation of rapid signal transducer and activator of transcription-5 phosphorylation in the resting cells of the growth plate and in the liver by growth hormone and feeding. Endocrinology 150: 3627-3636.
14. Kliewer, S.A. & D.J. Mangelsdorf 2010. Fibroblast growth factor 21: from pharmacology to physiology. Am. J. Clin. Nutr. 91: 254S-257S.
15. Galman, C., T. Lundasen, A. Kharitonenkov, et al 2008. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPAR alpha activation in man. Cell Metab. 8: 169-174.
16. Fazeli, P.K., M. Misra, M. Goldstein, et al 2010. Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. J. Clin. Endocrinol. Metab. 95: 369-374.
17. Henry, B.A., A. Rao, A.J. Tilbrook & I.J. Clarke 2001. Chronic food-restriction alters the expression of somatostatin and growth hormone-releasing hormone in the ovariectomized ewe. J. Endocrinol. 170: R1-R5.
18. Cordoba-Chacon, J., M.D. Gahete, J.P. Castano, et al 2010. Somatostatin and its receptors contribute, in a tissue-specific manner, to the gender-dependent, metabolic (fed/fasting) control of growth hormone axis in mice. Am. J. Physiol. Endocrinol. Metab. [Epub ahead of print] PMID: 20943754.
19. Cordoba-Chacon, J., M.D. Gahete, M. Duran-Prado, et al 2010. Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents. Cell. Mol. Life Sci. 67: 1147-1163.
20. Park, S., S. Sohn & R.D. Kineman 2004. Fasting-induced changes in the hypothalamic-pituitary-GH axis in the absence of GH expression: lessons from the spontaneous dwarf rat. J. Endocrinol. 180: 369-378.
21. Sugihara, H., N. Emoto, T. Shibasaki, et al 1996. Increased pituitary growth hormone-releasing factor (GRF) receptor messenger ribonucleic acid expression in food-deprived rats. Brain Res. 742: 355-358.
22. Bruno, J.F., Y. Xu, J. Song & M. Berelowitz 1994. Pituitary and hypothalamic somatostatin receptor subtype messenger ribonucleic acid expression in the food-deprived and diabetic rat. Endocrinology 135: 1787-1792.
23. Kim, M.S., C.Y. Yoon, K.H. Park, et al 2003. Changes in ghrelin and ghrelin receptor expression according to feeding status. Neuroreport 14: 1317-1320.
24. Tannenbaum, G.S., J.C. Painson, A.M.J. Lengyel & P. Brazeau 1989. Paradoxical enhancement of pituitary growth hormone (GH) responsiveness to GH-releasing factor in the face of high somatostatin tone. Endocrinology 124: 1380-1388.
25. Rigamonti, A.E., N. Marazzi, G. Cella, et al 1998. Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and fasted dogs: effect of somatostatin infusion or pretreatment with pirenzepine. J. Endocrinol. 156: 341-348.
26. Takahashi, H., Y. Kurose, Y. Suzuki, et al 2009. Ghrelin differentially modulates the GH secretory response to GHRH between the fed and fasted states in sheep. Domest. Anim. Endocrinol. 37: 55-60.
27. Aleppo, G., S.F. Moskal, II, P.A. Degrandis, et al 1997. Homologous down-regulation of growth hormone-releasing hormone receptor messenger ribonucleic acid levels. Endocrinology 138: 1058-1065.
28. Kineman, R.D., J. Kamegai & L.A. Frohman 1999. Growth hormone-releasing hormone (GHRH) and the growth hormone secretagogue (GHS), L692, 585, differentially modulate rat pituitary GHS receptor (GHS-R) and GHRH receptor (GHRH-R) mRNA levels. Endocrinology 140: 3581-3586.
29. Luque, R.M., R.D. Kineman, S. Park, et al 2004. Homologous and heterologous regulation of pituitary receptors for ghrelin and growth hormone-releasing hormone. Endocrinology 145: 3182-3189.
30. Kineman, R.D. & R.M. Luque 2007. Evidence that ghrelin is as potent as growth hormone (GH)-releasing hormone (GHRH) in releasing GH from primary pituitary cell cultures of a nonhuman primate (Papio anubis), acting through intracellular signaling pathways distinct from GHRH. Endocrinology 148: 4440-4449.
31. Unger, J., T.H. Mcneill, R.T. Moxley, 3rd, et al 1989. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 31: 143-157.
32. Lesniak, M.A., J.M. Hill, W. Kiess, et al 1988. Receptors for insulin-like growth factors I and II: autoradiographic localization in rat brain and comparison to receptors for insulin. Endocrinology 123: 2089-2099.
33. Marks, J.L., D. Porte, Jr. & D.G. Baskin 1991. Localization of type I insulin-like growth factor receptor messenger RNA in the adult rat brain by in situ hybridization. Mol. Endocrinol. 5: 1158-1168.
34. Itoh, M. 1979. Immunoreactive somatostatin in the hypothalamus and other regions of the rat brain: effects of insulin, glucose, alpha- or beta-blocker and L-dopa. Endocrinol. Jpn. 26: 41-58.
35. Sato, M. & L.A. Frohman 1993. Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone (GRH) and somatostatin gene expression in GH-deficient dwarf rats. Endocrinology 133: 793-799.
36. Melmed, S., S. Yamashita, H. Yamasaki, et al 1996. IGF-I receptor signalling: lessons from the somatotroph. Rec. Prog. Horm. Res. 51: 189-215.
37. Sugihara, H., N. Emoto, H. Tamura, et al 1999. Effect of insulin-like growth factor-I on growth hormone-releasing factor receptor expression in primary rat anterior pituitary cell culture. Neurosci. Lett. 276: 87-90.
38. Kamegai, J., H. Tamura, T. Shimizu, et al 2005. Insulin-like growth factor-I regulates ghrelin receptor (growth hormone secretagogue receptor) expression in the rat pituitary. Regul. Pept. 127: 203-206.
39. Luque, R.M., M.D. Gahete & R.D. Kineman 2005. Comparison of the effects of insulin and IGF-I on expression of growth hormone (GH), GH-releasing hormone receptors (GHRH-R) and ghrelin receptors (GHS-R), in primary pituitary cell cultures of mice and baboons (papio anubis) [abstract]. Endocrine Society Meetings, San Diego, CA, pp. 2-11.
40. Luque, R.M., M.D. Gahete, R.J. Valentine & R.D. Kineman 2006. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis. J. Mol. Endocrinol. 37: 25-38.
41. Kojima, M. & K. Kangawa 2005. Ghrelin: structure and function. Physiol. Rev. 85: 495-522.
42. Van Der Lely, A.J., M. Tschop, M.L. Heiman & E. Ghigo 2004. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev. 25: 426-457.
43. Hassouna, R., P. Zizzari & V. Tolle 2010. The ghrelin/obstatin balance in the physiological and pathological control of growth hormone secretion, body composition and food intake. J. Neuroendocrinol. 22: 793-804.
44. Date, Y., N. Murakami, M. Kojima, et al 2000. Central effects of a novel acylated peptide, ghrelin on growth release in rats. Biochem. Biophys. Res. Commun. 275: 477-480.
45. Le Roux, C.W., N.M. Neary, T.J. Halsey, et al 2005. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J. Clin. Endocrinol. Metab. 90: 4521-4524.
46. Osterstock, G., P. Escobar, V. Mitutsova, et al 2010. Ghrelin stimulation of growth hormone-releasing hormone neurons is direct in the arcuate nucleus. PLoS One 5: e9159.
47. Yamazaki, M., K. Nakamura, H. Kobayashi, et al 2002. Regulational effect of ghrelin on growth hormone secretion from perifused rat anterior pituitary cells. J. Neuroendocrinol. 14: 156-162.
48. Malagon, M.M., R.M. Luque, E. Ruiz-Guerrero, et al 2003. Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes. Endocrinology 144: 5372-5380.
49. Yang, H., V.D. Dixit, K. Patel, et al 2008. Reduction in hypophyseal growth hormone and prolactin expression due to deficiency in ghrelin receptor signaling is associated with Pit-1 suppression: relevance to the immune system. Brain Behav. Immun. 22: 1138-1145.
50. Zhao, T.J., G.S. Liang, R.L. Li, et al 2010. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc. Natl. Acad. Sci. U.S.A. 107: 7467-7472.
51. Nass, R., L. Farhy, J. Liu, et al 2008. Evidence for acyl-ghrelin modulation of growth hormone release in the fed state. J. Clin. Endocrinol. Metab. 93: 1988-1994.
52. Espelund, U., T.K. Hansen, K. Hojlund, et al 2005. Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects. J. Clin. Endocrinol. Metab. 90: 741-746.
53. Kamegai, J., H. Tamura, T. Shimizu, et al 2001. Regulation of the ghrelin gene: growth hormone-releasing hormone upregulates ghrelin mRNA in the pituitary. Endocrinology 142: 4154-4157.
54. Kamegai, J., A. Tamura, T. Shimizu, et al 2004. The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content. Endocrinology 145: 3731-3738.
55. Kedzai, A., M. Obara-Moscynska & M. Chmielnicka-Kopaxzyk 2009. Assessment of ghrelin, GHS-R, GH, and neurohormones in human fetal pituitary glands and central nervous system: and immunohistochemical study. Folia Histochem. Cytobiol. 47: 505-510.
56. Gahete, M.D., J. Cordoba-Chacon, R. Salvatori, et al 2010. Metabolic regulation of ghrelin O-acyl transferase (GOAT) expression in the mouse hypothalamus, pituitary, and stomach. Mol. Cell. Endocrinol. 317: 154-160.
57. Sato, T., Y. Fukue, H. Teranishi, et al 2005. Molecular forms of hypothalamic ghrelin and its regulation by fasting and 2-deoxy-D-glucose administration. Endocrinology 146: 2510-2516.
58. Tamaki, M., M. Sato, S. Matsubara, et al 1996. Dexamethasone increases growth hormone (GH)-releasing hormone (GRH) receptor mRNA levels in cultured rat anterior pituitary cells. J. Neuroendocrinol. 8: 475-480.
59. Miller, T.L. & K.E. Mayo 1997. Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression. Endocrinology 138: 2458-2465.
60. Tamura, H., J. Kamegai, H. Sugihara, et al 2000. Glucocorticoids regulate pituitary growth hormone secretagogue receptor gene expression. J. Neuroendocrinol. 12: 481-485.
61. Park, S., J. Kamegai & R.D. Kineman 2003. Role of glucocorticoids in the regulation of pituitary somatostatin receptor subtype (sst1-sst5) mRNA levels: evidence for direct and somatostatin-mediated effects. Neuroendocrinology 78: 163-175.
62. Kim, E., S. Sanghee, H. Chung & S. Park 2008. Role of glucocorticoids in fasting-induced changes in hypothalamic and pituitary components of the growth hormone (GH)-axis. Korean J. Physiol. Pharmacol. 12: 217-233.
63. Scacchi, M., A.I. Pincelli & F. Cavagnini 1999. Growth hormone in obesity. Int. J. Obes. Relat. Metab. Disord. 23: 260-271.
64. Maccario, M., S. Grottoli, M. Procopio, et al 2000. The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors. Int. J. Obes. Relat. Metab. Disord. 24: S96-S99.
65. Lanzi, R., L. Luzi, A. Caumo, et al 1999. Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects. Metabolism 48: 1152-1156.
66. Maccario, M., G. Aimaretti, S. Grottoli, et al 2001. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. Int. J. Obes. Relat. Metab. Disord. 25: 1233-1239.
67. Bonert, V.S., J.D. Elashoff, P. Barnett & S. Melmed 2004. Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency. J. Clin. Endocrinol. Metab. 89: 3397-3401.
68. Haijima, S.V., P.S. Van Dam, W.R. De Vries, et al 2005. The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men. Eur. J. Endocrinol. 152: 575-580.
69. Qu, X.-D., I.T. Gaw Gonzalo, M.Y. Al Syed, et al 2004. Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests. J. Clin. Endocrinol. Metab. 90: 1563-1569.
70. Cordido, F., P. Alvarez-Castro, M.L. Isidro, et al 2003. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. Eur. J. Endocrinol. 149: 117-122.
71. Kaushal, K. & S.M. Shalet 2007. Defining growth hormone status in adults with hypopituitarism. Horm. Res. 68: 185-194.
72. Vahl, N., J.O. Jorgensen, C. Skjaerbaek, et al 1997. Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am. J. Physiol. 272: E1108-E1116.
73. Pijl, H., J.G. Langendonk, J. Burggraaf, et al 2001. Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J. Clin. Endocrinol. Metab. 86: 5509-5515.
74. De Marinis, L., A. Bianchi, A. Mancini, et al 2004. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition. Endocrinology 89: 174-180.
75. Luque, R.M. & R.D. Kineman 2006. Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function. Endocrinology 147: 2754-2763.
76. Cattaneo, L., V. De Gennaro-Colonna, M. Zoli, et al 1996. Characterization of the hypothalamo-pituitary-IGF-I axis in rats made obese by overfeeding. J. Endocrinol. 148: 347-353.
77. Ghigo, E., M. Procopio, M. Maccario, et al 1993. Repetitive GHRH administration fails to increase the response to GHRH in obese subjects: evidence for a somatotrope defect in obesity? Horm. Metab. Res. 25: 305-308.
78. Yeagley, D., S. Guo, T. Unterman & P.G. Quinn 2001. Gene- and activation-specific mechanisms for insulin inhibition of basal and glucocorticoid-induced insulin-like growth factor binding protein-1 and phosphoenolpyruvate carboxykinase transcription. Roles of forkhead and insulin response sequences. J. Biol. Chem. 276: 33705-33710.
79. Maccario, M., F. Tassone, L. Gianotti, et al 2001. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (GH) response to GH-releasing hormone in obesity. J. Clin. Endocrinol. Metab. 86: 167-171.
80. Carmichael, J.D., A. Danoff, D. Milani, et al 2006. GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90. Clin. Endocrinol. 65: 169-177.
81. Tschop, M., C. Weyer, P.A. Tataranni, et al 2001. Circulating ghrelin levels are decreased in human obesity. Diabetes 50: 707-709.
82. Shiiya, T., M. Nakazato, M. Mizuta, et al 2002. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J. Clin. Endocrinol. Metab. 87: 240-244.
83. St Pierre, D.H., A.D. Karelis, L. Coderre, et al 2007. Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women. J. Clin. Endocrinol. Metab. 92: 264-269.
84. Barazzoni, R., M. Zanetti, C. Ferreira, et al 2007. Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. J. Clin. Endocrinol. Metab. 92: 3935-3940.
85. Wiedmer, P., R. Nogueiras, F. Broglio, et al 2007. Ghrelin, obesity and diabetes. Nat. Clin. 3: 705-712.
86. Luque, R.M., Z.H. Huang, B. Shah, et al 2007. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice. Am. J. Physiol. Endocrinol. Metab. 292: E891-E899.
87. Childs, G.V., N. Akhter, A. Haney, et al 2010. The somatotrope as a metabolic sensor:deletion of leptin receptors causes obesity. Endocrinology. [Epub ahead of print] PMID: 21084451.
88. Saleri, R., A. Giustina, C. Tamanini, et al 2004. Leptin stimulates growth hormone secretion via a direct pituitary effect combined with a decreased somatostatin tone in a median eminence-pituitary perifusion study. Neuroendocrinology 79: 221-228.
89. Mizuno, I., Y. Okimura, Y. Takahashi, et al 1999. Leptin stimulates basal and GHRH-induced GH release from cultured rat anterior pituitary cells in vitro. Kobe J. Med. Sci. 45: 221-227.
90. Rodriguez-Pacheco, F., A.J. Martinez-Fuentes, S. Tovar, et al 2007. Regulation of pituitary cell function by adiponectin. Endocrinology 148: 401-410.
91. Rodriguez-Pacheco, F., R. Vazquez-Martinez, A.J. Martinez-Fuentes, et al 2009. Resistin regulates pituitary somatotrope cell function through the activation of multiple signaling pathways. Endocrinology 150: 4643-4652.
92. Penalva, A., B. Burguera, X. Casabiell, et al 1989. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin. Neuroendocrinology 49: 551-554.
93. Renier, G. & O. Serri 1991. Effects of acute and prolonged glucose excess on growth hormone release by cultured rat anterior pituitary cells. Neuroendocrinology 54: 521-525.
94. Barb, C.R., R.R. Kraeling & G.B. Rampacek 1995. Glucose and free fatty acid modulation of growth hormone and luteinizing hormone secretion by cultured porcine pituitary cells. J. Anim. Sci. 73: 1416-1423.
95. Moller, L., H. Norrelund, N. Jessen, et al 2009. Impact of growth hormone receptor blockade on substrate metabolism during fasting in healthy subjects. J. Clin. Endocrinol. Metab. 94: 4524-4532.
96. Luque, R.M., G. Amargo, S. Ishii, et al 2007. Reporter expression, induced by a GH promoter-driven Cre recombinase (rGHp-Cre) transgene, questions the developmental relationship between somatotropes and lactotropes in the adult mouse pituitary gland. Endocrinology 148: 1946-1953.
97. Behringer, R.R., L.S. Mathews, R.D. Palmiter & R.L. Brinster 1988. Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes Dev. 2: 453-461.
98. Burton, F.H., K.W. Hasel, F.E. Bloom & J.G. Sutcliffe 1991. Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene. Nature 350: 74-77.
99. Kloting, N., L. Koch, T. Wunderlich, et al 2008. Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth. Diabetes 57: 2074-2082.
100. Bruning, J.C., M.D. Michael, J.N. Winnay, et al 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2: 559-569.
101. Luque, R.M., J. Cordoba-Chacon, Q. Lin, et al 2010. Use of the Cre-loxP system to dissect out the individual roles IGF-I receptors (IGFIR) and insulin receptors (INSR) play in mediating somatotrope function, in vitro and in vivo[abstract]. Endocr. Rev. 31(Suppl. 1): S1954.
102. Luque, R.M., M.D. Gahete, J. Cordoba-Chacon, et al 2010. The interrelationship between GH and metabolism: the somatotrope as a metabolic sensor [abstract]. Presented at the International Congress of Neuroendocrinology, Rouen, France, July 12.
103. Romero, C.J., Y. Ng, R.M. Luque, et al 2010. Targeted deletion of somatotroph insulin-like growth factor-I signaling in a cell-specific knockout mouse model. Mol. Endocrinol. 24: 1077-1089.
104. Balthasar, N., R. Coppari, J. Mcminn, et al 2004. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 42: 983-991.
105. Bockamp, E., M. Maringer, C. Spangenberg, et al 2002. Of mice and models: improved animal models for biomedical research. Physiol. Genomics 11: 115-132.
106. Morozov, A. 2008. Conditional gene expression and targeting in neuroscience research. In Current Protocols in Neuroscience. C.R. Gerfen et al., Eds.: Chapter 4, Unit 4.31, 1-10. John Wiley & Sons, Inc. Hoboken, NJ
107. Moller, N. & J.O.L. Jorgensen 2009. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30: 152-177.